The relocation of Hamad Medical Corporation’s (HMC) Audiology and Balance Unit from Rumailah Hospital to the Ambulatory Care Center (ACC) last year has enabled care teams to serve more patients, with more than 26,000 patient visits recorded in the last 14 months.
Dr Khalid Abdul Hadi, senior consultant, Hearing and Balance Disorders and director of the Audiology and Balance Unit, said moving to the new hospital in June last year has also provided capacity for new services, including new technology that will enable"...

Doha
Hamad Medical Corporation (HMC) officially opened its state-of-the-art Trauma and Emergency Center at Hamad General Hospital recently.
At the inauguration, the new Hyperbaric Therapy Unit was also officially opened, highlighting one of the many cutting-edge therapies HMC is bringing to Qatar.
Dr Kokash Osama, senior consultant, Anaesthesia, and head of HMC’s Hyperbaric Oxygen Therapy Programme, said that while hyperbaric oxygen therapy has been available at HMC since 2013, the new Hyperbaric Therapy"...

SIDRA Medicine transmitted live via broadband WiFi, interventional cardiac procedures from its cardiac catheterisation laboratories in Qatar to a delegation of over 800 healthcare professionals at the 22nd Annual Pediatric and Adult Interventional Cardiac Symposium (PICS-AICS) in San Diego in the United States.
PICS-AICS is one of the largest cardiac symposiums dedicated to the latest breakthroughs in the treatment of patients with congenital and structural heart diseases. Prof Ziyad M Hijazi is the chairman of PICS-AICS,"...

Polycystic Ovarian Syndrome (PCOS) is among the most common causes of infertility among women in the UAE. In order to address this issue, during the ‘PCOS Awareness Month’ in September, Fakih IVF is looking to reach out to all women by providing them with services that would educate them more on the subject.

PCOS is the most common endocrinopathy (hormonal disturbance) affecting reproductive aged women, with a prevalence of between 8"...

“Walk-in patients arriving at the new Trauma and Emergency Center’s Emergency Department will be triaged upon and after initial assessment and patients will either be admitted to the hospital or discharged. To further boost capacity, the See and Treat area of the former Emergency Department will also remain open.” The new facility will also expand and improve upon HMC’s capacity to care for patients in need of trauma care with the first floor housing the Hamad Trauma Center, Qatar’s major trauma"...

Doha
Ezdan Holding Group and Qatar Aluminium Manufacturing Company (Qamco) will replace Medicare Group and Qatar First Bank in the QE Index with effect from October 1 this year, Qatar Stock Exchange (QSE) has said in a statement on its website.
The QSE, which had announced about a methodology change to all QSE indices effective from October 1 as approved by QSE Index Committee and QFMA, said Ezdan Holding, Qamco and Qatar Islamic Insurance will also join QE Al Rayan Islamic Index.
While Qamco will also join"...

THE Qatar Foundation for Social Work’s Center of Empowerment and Elderly Care (Ehsan) has launched an awareness campaign in tandem with World Alzheimer’s Day, which is observed on September 21 every year.
The campaign seeks to raise awareness of the disease, its causes, symptoms, stages, prevention methods and the most important guidelines for dealing with Alzheimer’s patients.
The awareness campaign, which runs until September 22, includes a series of events and activities aimed at raising awareness,"...

Samsung Bioepis Co., Ltd. today announced its expansion into the Brazilian biopharmaceutical market. The first product available in the country is BRENZYS™ (etanercept), a biosimilar referencing ENBREL®.i BRENZYS™ was approved by Agência Nacional de Vigilância Sanitária (ANVISA), the country’s health regulatory agency, in December 2017 for the treatment of rheumatoid arthritis, ankylosing spondylitis, plaque psoriasis, psoriatic arthritis, and non-radiographic axial spondyloarthritis.

Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces that it has initiated investigational new drug (IND)-enabling studies for ALS-4, a small drug molecule candidate indicated for the treatment of infections caused by Staphylococcus aureus (or “S. aureus”) including methicillin-resistant Staphylococcus aureus (MRSA, i.e., one of the commonly known “super-bugs”)"...

Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces the development of two preclinical drug candidates which target obesity and neuroblastoma, respectively.

About CLS-1: Treatment of obesity via modulation of chemical signaling relating to gut microbiota

Under"...